Quadlytics Inc.

Philosophy

Vision

Creating a future where humanity can live without fear of epileptic seizure.


Mission

Leveraging the quadruple specialty;
sensing,
data analysis,
machine learning,
and clinical medicine,
we realize epileptic seizure prediction
through real-time autonomic nervous system analytics
for preventing injuries and accidents and providing peace of mind and safety to patients and their families.

Value

  1. Patient-Centric Approach

    Prioritizing the needs and safety of patients, always providing products and services from the patient’s perspective.

  2. Technology and Innovation

    Utilizing cutting-edge biosensing and analytics technologies, along with machine learning, to explore new possibilities in epilepsy treatment.

  3. Trust and Transparency

    Operating with high ethical standards and transparency, building trust with patients, healthcare professionals, and partners.

  4. Global Reach

    Offering innovative solutions not only in Japan but also to epilepsy patients worldwide, contributing to global health improvement.

  5. Sustainability

    Developing sustainable medical solutions with a long-term perspective.

Service

Business

“Heartful services”:  predictive offerings for health, safety, and security

  • Our unique strengths allows for richly-detailed heart rate variability analytics that tracks the autonomic system
  • We are a rare group of experts that can offer accurate predictive services through a mobile package
  • Through our unique predictive offerings we want to contribute to modern health, safety & security needs
  • Our service model is based on Data Platform where HRV data accumulate.

Technologies

  • We use the Heart rate variability (HRV), which is controlled by cardiac autonic neurons,
    directly reflects autonomic nervous system(ANS) functioning.
  • We are accumulating HRV data across various (patho) physiological and psychological states
    to refine discrimination powers

Our unique strengths, “SAFE”

S =Sensing
Wearable
medical-grade sensor
A =Analytics
Multi-day continuous
analysis
F =Future
Predictive feedback
providing timely responses
E =Empowerment
Smartphone-enabled
mobile apps
→Enable early intervention and self-management by offering these strengths above

Mobile Apps with algorithms based on continuous and real-time analytics

 

Screen images of apps showing continuous and real-time analytics

Research

Our technologies are based on several basic researches
from mainly Kyoto university and Kumamoto university,
which company’s staffs have been conducted.

Background of our research

Our beginning is that we want to solve problems driven by epilepsy seizure
by using our high quality technologies.

Epilepsy is a common neurological disease that affects people of all ages. Approximately 30% of
epileptic patients cannot achieve seizure control even if they are treated with the best available medications.
Seizures associated with convulsion and/or loss of consciousness can causes serious injuries not only to patients themselves but also to people around them. Furthermore, uncontrolled seizures are a risk factor for sudden unexpected death in epilepsy (SUDEP). A seizure prediction technology can greatly benefit patients by allowing self-control to avoid medical, physical, and psychosocial harms.

Our core technologies – AI informatics and biomedical sensors – were originally built in Kyoto University and Kumamoto University, respectively. Through their joint efforts our technologies, most prominent of which is epileptic seizure prediction, have come to fruition. We conduct collaborative research with specialist facilities all around the country.

Company

NameQuadlytics Inc.
EstablishedFebruary 9th, 2018
Capital3million
Address

 134 Chudoji Minamimachi, Shimogyo-ku, Kyoto 600-8813 Japan

Chief Executive
Officer
Kohei Hayashi
Board MemberToshitaka Yamakawa
Our business-Medical device research and development
-Software development
-Consulting service in data-analysis, machine learning, and medical services
Access

134 Chudoji Minamimachi, Shimogyo-ku, Kyoto 600-8813 Japan
TEL. +81−75−606−5077

Member

Kohei Hayashi(MMSc.)
Chief Executive Officer

Kohei Hayashi
MMSc.

PROFILE

Career

Formerly Nomura Research Institute & University of Tokyo Graduate School of Medicine

Role
Service design, implementation and collaboration for individuals and organizations
Toshitaka Yamakawa(PhD.)
Chief Technology Officer

Toshitaka Yamakawa
PhD.

PROFILE

Career

Assistant Professor, Kumamoto University Faculty of Engineering

Role
Medical-grade sensor technology truly wearable continuously for multiple days

Recruit

We’re not recruiting at the moment.

Inquiry